Last reviewed · How we verify
NCT03362528
Database and Calibration of a Non-invasive Glucose Monitoring Device
NA trial testing WM3.4NR in Diabetes in 12 participants. Completed in 28 January 2019.
28 January 2019
Quick facts
| Lead sponsor | RSP Systems A/S |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 12 |
| Start date | 25 September 2017 |
| Primary completion | 28 January 2019 |
| Estimated completion | 28 January 2019 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- WM3.4NR
Conditions studied
- Diabetes — all drugs for Diabetes →
Sponsor
RSP Systems A/S
Who can join
18 and older, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study has been launched to collect spectral raman data paired with validated glucose reference values in private homes of subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03362528
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of WM3.4NR
Trials testing the same drug.
- NCT03530644 — Comparative Study Between Two Models of a Non-invasive Glucose Monitoring Device · NA · completed
- NCT03352518 — Performance Characteristics and Safety Assessment of a Non-invasive Glucose Monitoring Device · NA · completed
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other RSP Systems A/S trials
Trials by the same sponsor.
- NCT05851469 — Study of a Non-invasive Glucose Measuring Device · NA · completed
- NCT04518813 — A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings · NA · completed
- NCT04060693 — Device Accuracy of Non-invasive Glucose Measurements in Ethnic Skin · NA · withdrawn
- NCT03782441 — Study of a Novel Non-invasive Glucose Monitoring Device · NA · completed
- NCT04033042 — Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions f · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03362528 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RSP Systems A/S
- Last refreshed: 4 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03362528.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing